My Size, Inc. Reports 30% Revenue Decline for First Half of 2025, Despite Acquisition of New Percentil

My Size, Inc. reported its financial results for the six months ending June 30, 2025, revealing a revenue of $3.485 million, a decline of 30% from $4.963 million in the same period of 2024. The decrease is primarily attributed to reduced sales from Orgad, one of its subsidiaries. However, the company experienced a slight increase in revenue for the three months ending June 30, 2025, which reached $2.006 million, compared to $1.979 million in the prior year, largely due to the inclusion of New Percentil, a recently acquired subsidiary.

The company's gross profit for the first half of 2025 was $1.544 million, down from $2.180 million in 2024. Operating expenses also decreased to $3.190 million from $4.128 million, driven by reductions in sales and marketing, as well as general and administrative expenses. Notably, My Size recorded an operating loss of $1.646 million for the six-month period, a 16% improvement compared to the $1.948 million loss in the same timeframe last year. The net loss for the first half of 2025 was $1.510 million, down from $1.980 million in 2024.

In terms of strategic developments, My Size completed the acquisition of New Percentil on May 9, 2025, which is expected to enhance its resale platform capabilities. The acquisition involved a total transaction value of approximately $679,000, including cash payments and the assumption of liabilities. This move is part of the company's strategy to expand its offerings in the apparel e-commerce market and improve its operational efficiencies.

Operationally, My Size reported a total of 3.1 million shares outstanding as of June 30, 2025, an increase from 2.04 million shares at the end of 2024, reflecting the issuance of shares under an At The Market Offering Agreement. The company had cash and cash equivalents of $4.282 million, down from $4.880 million at the end of 2024, indicating a need for ongoing capital to support operations. The company continues to face challenges, including an accumulated deficit of $65.386 million and uncertainty regarding its ability to sustain operations beyond 12 months without additional capital.

Looking ahead, My Size anticipates continued losses and negative cash flows, emphasizing the need for further financing to support its operations and growth initiatives. Management is actively seeking opportunities to commercialize its products and secure additional funding through equity sales or strategic partnerships. The company remains cautious about the geopolitical situation in Israel and its potential impact on operations, although it has not yet materially affected its financial results.